Literature DB >> 2978371

Characteristics and uses of natural killer cells.

T Hercend, R E Schmidt.   

Abstract

Mesh:

Substances:

Year:  1988        PMID: 2978371     DOI: 10.1016/0167-5699(88)91317-5

Source DB:  PubMed          Journal:  Immunol Today        ISSN: 0167-5699


× No keyword cloud information.
  32 in total

1.  Functional impairment of natural killer cells in active ulcerative colitis: reversion of the defective natural killer activity by interleukin 2.

Authors:  L Manzano; M Alvarez-Mon; L Abreu; J Antonio Vargas; E de la Morena; F Corugedo; A Duràntez
Journal:  Gut       Date:  1992-02       Impact factor: 23.059

Review 2.  Bronchoalveolar lavage and the immunology of lung cancer.

Authors:  G Semenzato; M Spatafora; C Feruglio; E Pace; V Dipietro
Journal:  Lung       Date:  1990       Impact factor: 2.584

Review 3.  Immune responses in the lung: basic principles.

Authors:  C Agostini; G Semenzato
Journal:  Lung       Date:  1990       Impact factor: 2.584

4.  NK cells inhibit T-cell responses: LFA3+ but not LFA3- T-cell responses are suppressed.

Authors:  P D Mason; G Lombardi; R I Lechler
Journal:  Immunology       Date:  1991-08       Impact factor: 7.397

5.  Heterogeneity of human natural killer cells in the spleen.

Authors:  T Witte; K Wordelmann; R E Schmidt
Journal:  Immunology       Date:  1990-01       Impact factor: 7.397

6.  Determination of natural killer cell function by flow cytometry.

Authors:  K L Kane; F A Ashton; J L Schmitz; J D Folds
Journal:  Clin Diagn Lab Immunol       Date:  1996-05

7.  Isolation and functional studies of granulated lymphocytes in first trimester human decidua.

Authors:  A Ritson; J N Bulmer
Journal:  Clin Exp Immunol       Date:  1989-08       Impact factor: 4.330

8.  Iso-immune neonatal neutropenia due to an anti-Fc receptor III (CD16) antibody.

Authors:  J Cartron; J L Celton; P Gane; A Astier; W H Fridman; G Boissinot; J P Cartron
Journal:  Eur J Pediatr       Date:  1992-06       Impact factor: 3.183

9.  Cytotoxic T lymphocyte activity to hepatitis B virus DNA-transfected HepG2 cells in patients with chronic hepatitis B.

Authors:  Y Ito; S Kakumu; K Yoshioka; T Wakita; T Ishikawa; K Koike
Journal:  Gastroenterol Jpn       Date:  1993-10

Review 10.  T cell targeting in cancer therapy.

Authors:  R L Bolhuis; E Sturm; E Braakman
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.